Innate Pharma S.A.
NASDAQ:IPHABiotechnology
Healthcare
$1.03 +1.91%
+$0.03 today
- Market cap
- $115.05M
- Beta
- 0.89
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$0.54
52W Low $1.17High $2.63
Volume 0.50M
Average 0.07M
Balance Sheet
Inspect the capital base behind the business.
Assets
$62.69M
FY 2025 · Annual
-43.6% YoYLiabilities
$84.39M
FY 2025 · Annual
-17.4% YoYEquity
-$21.69M
FY 2025 · Annual
Balance Sheet
EUR
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 103.76M | 84.23M | 70.61M | 66.4M | 28.08M |
| Short-term Investments | 16.08M | 17.26M | 21.85M | 14.37M | 6.22M |
| Net Receivables | 1.66M | 3.14M | 46.49M | 1.64M | 7.61M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 11.81M | 27.88M | 0 | 0 | (4.28K) |
| Total Current Assets | 138.26M | 139.83M | 148.01M | 85.74M | 46.69M |
| Property, Plant & Equipment (Net) | 10.17M | 8.54M | 6.32M | 5.13M | 4.35M |
| Goodwill | 2K | (41M) | 0 | 0 | 0 |
| Intangible Assets | 44.19M | 42.55M | 416K | 0 | 0 |
| Long-term Investments | 39.88M | 35.12M | 9.8M | 10.28M | 10.7M |
| Tax Assets | 5.03M | 8.57M | 9.01M | 0 | 0 |
| Other Non-current Assets | 29.97M | 14.25M | 1.64M | 9.9M | 946.6K |
| Total Non-current Assets | 129.24M | 68.03M | 27.18M | 25.32M | 16M |
| Total Assets | 267.5M | 207.86M | 175.19M | 111.06M | 62.69M |
| Account Payables | 14.73M | 13.66M | 8.56M | 7.92M | 15.04M |
| Short-term Debt | 29.94M | 1.26M | 8.45M | 8.44M | 8.52M |
| Tax Payables | 7.46M | 5.98M | 7.02M | 6.96M | 0 |
| Deferred Revenue | 12.5M | 6.56M | 5.87M | 616K | 2.82M |
| Other Current Liabilities | 21.91M | 19.02M | 7.82M | 7.65M | 9.97M |
| Total Current Liabilities | 79.89M | 41.34M | 39.64M | 32.98M | 36.63M |
| Long-term Debt | 11.49M | 38.93M | 30.61M | 22.18M | 13.67M |
| Deferred Tax Liabilities | 5.03M | 8.57M | 9.01M | 0 | 0 |
| Deferred Revenue (Non-current) | 25.41M | 7.92M | 4.62M | 2.83M | 0 |
| Other Non-current Liabilities | 36.23M | 55.74M | 39.07M | 44.13M | 33.99M |
| Total Non-current Liabilities | 80.17M | 112.37M | 83.65M | 69.24M | 47.75M |
| Total Liabilities | 160.06M | 153.71M | 132.29M | 102.23M | 84.39M |
| Common Stock | 3.98M | 4.01M | 4.04M | 4.19M | 4.69M |
| Retained Earnings | (272.21M) | (330.32M) | (336.89M) | (386.36M) | (435.36M) |
| Accumulated OCI | 456K | 819K | 495K | 27K | 1.12M |
| Other Stockholders Equity | (1K) | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 107.44M | 54.15M | 51.9M | 8.83M | (21.69M) |
| Total Debt | 44.25M | 42.25M | 39.89M | 31M | 22.56M |
| Net Debt | (59.51M) | (41.97M) | (30.71M) | (35.4M) | (5.52M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $28.1M |
| Short-term Investments | $6.2M |
| Receivables | $7.6M |
| Other Current | $4.8M |
| Total Current Assets | $46.7M |
| PP&E (Net) | $4.4M |
| Long-term Investments | $10.7M |
| Other Non-current | $946.6K |
| Total Non-current Assets | $16.0M |
| Total Assets | $62.7M |
Analysis
Selected assets total $62.7M for Latest. The largest visible component is Cash & Equivalents at $28.1M, about 44.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 12, 2026 | |
| 6-K | 6-K filing | Nov 5, 2026 | |
| 6-K | 6-K filing | Oct 27, 2026 | |
| 6-K | 6-K filing | Oct 21, 2026 | |
| 6-K | 6-K filing | Oct 20, 2026 |
How much cash does IPHA have?
Innate Pharma S.A. (IPHA) reported $28.08M in cash and equivalents in fiscal 2025.
How much debt does IPHA carry?
Innate Pharma S.A. (IPHA) reported $22.56M of total debt, with net debt of -$5.52M.
Continue the stock analysis
Jump to another research area for this company.